SCHEMBL765757

SCHEMBL765757

Cc1ccc(-c2ccc(CC(C)C)cc2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.50
CCR5 P51681 1/20 0.50
CCR8 P51685 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
CYP3A4 P08684 2/20 0.45
CYP2A6 P11509 1/20 0.45
AURKA O14965 1/20 0.44
ABL1 P00519 1/20 0.44
NTRK1 P04629 1/20 0.44
LCK P06239 1/20 0.44
CSF1R P07333 1/20 0.44
RET P07949 1/20 0.44
MET P08581 1/20 0.44
PDGFRB P09619 1/20 0.44
PIM1 P11309 1/20 0.44
PDGFRA P16234 1/20 0.44
FLT3 P36888 1/20 0.44
MAPK8 P45983 1/20 0.44
CDK8 P49336 1/20 0.44
MAP2K1 Q02750 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14227278 0.90 AURKA (0.51) CCR1CCR5CCR8HDAC6CYP3A4
SCHEMBL10332074 0.83 RAB9A (0.58) XDHPTPN1NPC1RAB9ASMN1; SMN2
SCHEMBL19398968 0.81 BRS3 (0.48) AURKAABL1NTRK1LCKCSF1R
SCHEMBL22275581 0.81 XDH (0.41) XDHCYP11B1CYP11B2PTPN1NPC1
SCHEMBL19862542 0.81 SLC6A2 (0.42) CYP3A4XDHPTPN1NPC1RAB9A
SCHEMBL18573123 0.81 XDH (0.48) XDHCYP11B1CYP11B2PTPN1NPC1
SCHEMBL17051514 0.81 CCR1 (0.75) CCR1CCR5CCR8HDAC6CYP3A4
SCHEMBL8233550 0.80 CCR1 (0.56) CCR1CCR5CCR8HDAC6CYP3A4
SCHEMBL18790914 0.80 CYP11B1 (0.47) CYP3A4CYP11B1CYP11B2NPC1RAB9A
SCHEMBL21342286 0.80 CYP11B1 (0.47) CYP3A4CYP11B1CYP11B2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240130-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-07-27 US disclosed
US-11653558-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-05-16 US disclosed
EP-2078015-B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1 AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240130-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBPL3, LBR, RBM3 CCR1 1517/4885CCR5 2032/4885CCR8 2403/4885
US-11653558-B2 Organic electroluminescent materials and devices OSBPL3, LBR, LOXL3 CCR1 1329/4885CCR5 2016/4885CCR8 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.